These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 6977902)
1. Thymus-dependent response: too little and too late for immunosurveillance. Lannin DR; Yu S; McKhann CF Transplantation; 1982 Jan; 33(1):99-100. PubMed ID: 6977902 [No Abstract] [Full Text] [Related]
2. Thymocytolytic autoantibodies elicited by immunization of mice with chemically-induced sarcoma and leukemia cells. Merino F Acta Cient Venez; 1982; 33(5):402-5. PubMed ID: 6985343 [No Abstract] [Full Text] [Related]
3. Murine splenic changes in response to syngeneic and allogeneic neoplasias. Braylan RC; Rumi L; Dosne Pasqualini C Medicina (B Aires); 1972; 32(5):505-10. PubMed ID: 4649563 [No Abstract] [Full Text] [Related]
4. CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen. Kennedy RC; Shearer MH; Watts AM; Bright RK Cancer Res; 2003 Mar; 63(5):1040-5. PubMed ID: 12615720 [TBL] [Abstract][Full Text] [Related]
6. The effect of Corynebacterium parvum on T cell dependent tumor regression. McBride WH; Peters LJ; Mason KA; Barrow G J Reticuloendothel Soc; 1980 Feb; 27(2):151-8. PubMed ID: 6965725 [No Abstract] [Full Text] [Related]
7. Radiation-induced changes in established tumor immunity. Vaage J; Doroshow JH; DuBois TT Cancer Res; 1974 Jan; 34(1):129-37. PubMed ID: 4809453 [No Abstract] [Full Text] [Related]
8. Identification of tumor-associated antigens on ultraviolet light-induced tumors using antitumor antibodies developed in ascites fluid. Fortner GW; Takemoto LJ; Shehi L; Hansen JS Cancer Res; 1982 Jun; 42(6):2371-4. PubMed ID: 7042083 [TBL] [Abstract][Full Text] [Related]
9. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro. Lynch DH; Gurish MF; Daynes RA Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587 [TBL] [Abstract][Full Text] [Related]
10. Naturally occurring antibodies against fibrosarcoma and glioma cells in rats. Itaya T; Moriuchi T; Kodama T; Sendo F; Kobayashi H Gan; 1982 Jun; 73(3):454-61. PubMed ID: 7129010 [No Abstract] [Full Text] [Related]
11. Dissociation between tumour resistance and delayed-type hypersensitivity to tumour-associated antigens in the mouse. Henderson DC; Parker D; Turk JL Immunology; 1980 Jan; 39(1):1-9. PubMed ID: 7380461 [TBL] [Abstract][Full Text] [Related]
12. [Aggregation of monoclonal antibody A2B5 on fibrosarcoma in mice]. Kidowaki T; Tanaka T; Sakamoto I; Ishii T; Kawakatsu S Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2605-6. PubMed ID: 6508317 [No Abstract] [Full Text] [Related]
13. [Immune responsiveness and resistance to bacterial infection in tumor bearing mice]. Kajiki A Fukuoka Igaku Zasshi; 1982 Dec; 73(12):697-710. PubMed ID: 7169207 [No Abstract] [Full Text] [Related]
14. Lysozyme enhancement of tumor cell immunoprotection in a murine fibrosarcoma. Warren JS; Rinehart JJ; Zwilling BS; Neidhart JA Cancer Res; 1981 May; 41(5):1642-5. PubMed ID: 7214334 [TBL] [Abstract][Full Text] [Related]
15. Effect of immunization of mice with syngeneic embryos on their ability to inhibit the growth of a challenging fibrosarcoma. Ray PK; Seshadri M Indian J Exp Biol; 1980 Sep; 18(9):1027-9. PubMed ID: 7203538 [No Abstract] [Full Text] [Related]